These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5052388)

  • 41. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation.
    Sarma A; Giugliano RP
    Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Source of error in the supervision of postoperative anticoagulant therapy].
    Senst W; Nowak W; Wolf E
    Zentralbl Chir; 1967; 92(26a Pt 1):1432-4. PubMed ID: 5595671
    [No Abstract]   [Full Text] [Related]  

  • 43. Anticoagulant treatment of thromboembolism with intravenous heparin therapy in the early postoperative period following total joint arthroplasty.
    Della Valle CJ; Jazrawi LM; Idjadi J; Hiebert RN; Stuchin SA; Steiger DJ; Di Cesare PE
    J Bone Joint Surg Am; 2000 Feb; 82(2):207-12. PubMed ID: 10682729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Remarks on the use of Ca heparinate by subcutaneous route in anticoagulant therapy].
    Vivien P
    Phlebologie; 1973; 26(1):15-21. PubMed ID: 4724445
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on the anticoagulant effect of heparin "in vivo" (author's transl)].
    Lucia JF; Ercoreca L; García Zueco JC; Cinto F; Raichs A
    Sangre (Barc); 1976; 21(1):77-86. PubMed ID: 772843
    [No Abstract]   [Full Text] [Related]  

  • 46. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.
    Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS
    Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New perspectives for treatment of pulmonary embolism.
    Simonneau G
    Haemostasis; 1998; 28 Suppl 3():95-9. PubMed ID: 10069768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Letter: Decreased sensitivity to oral anticoagulant therapy after attacks of migraine.
    Narasimhan P
    Lancet; 1974 Nov; 2(7889):1143. PubMed ID: 4139440
    [No Abstract]   [Full Text] [Related]  

  • 49. Anticoagulant potency of mucosal and lung heparin.
    McMahon FG; Jain AK; Ryan JR; Lefton TE
    Clin Pharmacol Ther; 1975 Jan; 17(1):79-82. PubMed ID: 1168110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants.
    Piovella F; Siragusa S; Barone M; Beltrametti C; Carbone S; Vicentini L; Ascari E
    Haematologica; 1995; 80(2 Suppl):87-91. PubMed ID: 7543072
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins?
    Baglin T
    J Thromb Haemost; 2012 Aug; 10(8):1702-3. PubMed ID: 22672412
    [No Abstract]   [Full Text] [Related]  

  • 52. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The heparin management test: a new device for monitoring anticoagulation during coronary intervention.
    Helft G; Bartolomeo P; Zaman AG; Worthley SG; Chokron S; Le Pailleur C; Beygui F; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Thromb Res; 1999 Dec; 96(6):481-5. PubMed ID: 10632472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal absorption of stable heparinic acid complexes.
    Koh TY; Bharucha KR
    J Lab Clin Med; 1972 Jul; 80(1):47-55. PubMed ID: 5033896
    [No Abstract]   [Full Text] [Related]  

  • 55. [Oral anticoagulant administration].
    Kiyose K; Fujita Y; Yamada T; Sakauchi H; Naka T
    Rinsho Byori; 1974 Oct; 22(10 Suppl):113. PubMed ID: 4475723
    [No Abstract]   [Full Text] [Related]  

  • 56. Early intravenous unfractioned heparin--also beneficial in acute lung injury?
    Hofstra JJ; Choi G; Schultz MJ;
    Crit Care Med; 2009 Apr; 37(4):1533-4; author reply 1534. PubMed ID: 19318861
    [No Abstract]   [Full Text] [Related]  

  • 57. Kinetics in normal humans of anticoagulant activity, radioactivity and lipolytic activity after intravenous administration of (S35) heparin and (S35) heparin fractions.
    De Swart CA; Sixma JJ; Andersson LO; Holmer E; Verschoor L; Nijmeyer A
    Scand J Haematol Suppl; 1980; 36():50-63. PubMed ID: 6935761
    [No Abstract]   [Full Text] [Related]  

  • 58. [Heparin-antivitamin K transfer].
    Fiessinger JN; Aïach M
    Rev Prat; 1988 May; 38(15):944, 947-51. PubMed ID: 3393836
    [No Abstract]   [Full Text] [Related]  

  • 59. [Problems posed by the control of oral anticoagulant therapy].
    Capel P
    Rev Med Brux; 1983 Jan; 4(1):23-6. PubMed ID: 6836203
    [No Abstract]   [Full Text] [Related]  

  • 60. ANTICOAGULANT THERAPY; APPRAISAL OF ITS LABORATORY CONTROL.
    WARE AG; STERLING RE; STRAGNELL R
    Angiology; 1964 Jan; 15():11-6. PubMed ID: 14104834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.